Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

An 8-year-old girl's eyebrow hair loss was linked to atomoxetine for ADHD but grew back after stopping the medication.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

People with certain skin disorders are more likely to have alcohol problems, especially if they also have mental health issues like depression and anxiety.

Squaric acid dibutylester effectively treats alopecia areata.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Vitamin D receptor gene changes don't affect alopecia areata risk.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

A new gene mutation causes insulin resistance in a girl and her mother.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

AI can accurately measure hair loss severity in alopecia areata.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

RDW can be a useful marker for inflammation in alopecia areata patients.

Childhood atopic dermatitis does not significantly affect general cognition.

Alopecia Areata is often linked to other health issues like allergies, thyroid problems, and diabetes.